Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites

Journal Title: Annals of Hepatology - Year 2014, Vol 13, Issue 3

Abstract

Introduction. The diagnosis of malignant ascites is a challenging problem in clinical practice, non-invasive techniques should be developed to improve diagnostic accuracy. The diagnostic performances of tumor markers in malignant ascites remained unsettled. Our aim was to evaluate diagnostic performance of tumor markers in differential diagnosis of benign and malignant ascites. Material and methods. A total of 437 patients were enrolled, and the relevant parameters of the patients were analyzed for the differentiation of benign ascites from malignant ascites. Results. At the predetermined cutoff values of tumor makers, tumor markers in ascitic fluid showed better diagnostic performance than those in serum. Combined use of tumor markers and the cytology increased the diagnostic yield of the latter by 37%. In cytologically negative malignant ascites, tumor markers provided assistance in differentiating malignant ascites from benign ascites, and the combination of ascitic tumor markers yielded 86% sensitivity, 97% specificity. Conclusion. Use of a panel of tumor markers exhibited excellent diagnostic performance in diagnosing malignant ascites, which indicated the detection of tumor markers may represent a beneficial adjunct to cytology, thus guiding the selection of patients who might benefit from further invasive procedures.

Authors and Affiliations

Liu Fang , Kong Xinjuan , Dou Qian , Ye Jin , Xu Dong , Shang Haitao , Song Yuhu

Keywords

Related Articles

Effects of Japanese herbal medicine inchin-ko-to on endotoxin-induced cholestasis in the rat

Background/Objective. Inchin-ko-to (ICKT) is an herbal medicine used in Japan to treat jaundice and liver fibrosis.We investigated the effect of oral ICKT supplementation on endotoxin-induced cholestasis in the rat. Mate...

Incidence and prognostic factors associated with biliary atresia in western India

Aim: To estimate the incidence of Biliary Atresia(BA) amongst Neonatal Cholestatic Syndromes (NCS) and determine prognostic factors in BA patients who have undergone Kasai’s portoenterostomy. Study design- Retrospective...

Genetic factors affecting susceptibility to alcoholic liver disease in an Indian population

Introduction. Indians are more likely to develop alcoholic cirrhosis compared to Caucasians, though the cause remains obscure. North Indians tend to consume more alcohol than other parts of the country. Genetic factors a...

The Changing Face of the Diagnosis of Chronic and Malignant Liver Diseases: Potential New Biomarkers

The early diagnosis of primary sclerosing cholangitis, hepatocellular carcinoma, and cholangiocarcinoma is often challenging. In a recent study in 134 patients (Arbelaiz, Hepatology 2017; 66:1125-1143), it was reported t...

Transforming growth factor ααααα immunoreactivity. A study in hepatocellular carcinoma and in non-neoplastic liver tissue

Background. Transforming growth factor alpha (TGFα) is an important mitogen that binds to epidermal growth factor receptor and is associated with the development of several tumors. Aims. Assessment of the immunoexpressi...

Download PDF file
  • EP ID EP78397
  • DOI -
  • Views 138
  • Downloads 0

How To Cite

Liu Fang, Kong Xinjuan, Dou Qian, Ye Jin, Xu Dong, Shang Haitao, Song Yuhu (2014). Evaluation of tumor markers for the differential diagnosis of benign and malignant ascites. Annals of Hepatology, 13(3), 357-363. https://europub.co.uk/articles/-A-78397